The market for secondary hyperparathyroidism treatment can be divided into three categories: treatment type, distribution channel, and geography. The market can be divided into two categories based on treatment type: surgery and pharmacological class. Vitamin D and derivatives, calcimimetics, and phosphate binders are subclasses of this pharmacological class.
Calcimimetics, a pharmacological class, are expected to expand significantly due to their capacity to attach to parathyroid cell receptors and decrease the level of calcium in blood serum. Furthermore, the growing product approvals of calcimimetics contribute to the segment's quick expansion. The market can be divided into two categories based on distribution channel: hospital pharmacies and retail pharmacies. During the projected period, the hospital pharmacies segment is expected to dominate the market.
Read more @ https://www.coherentmarketinsights.com/market-insight/secondary-hyperparathyroidism-treatment-market-1570
